Literature DB >> 7605434

Life-threatening human parvovirus B19 infection in immunocompetent haemophilia.

T T Yee, C A Lee, K J Pasi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7605434     DOI： 10.1016/s0140-6736(95)90673-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Parvovirus B19 - Revised.

Authors:  Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2010-11-17       Impact factor: 3.747

Review 2.  Parvovirus B19: an expanding spectrum of disease.

Authors:  B Cohen
Journal:  BMJ       Date:  1995-12-09

3.  SEROPREVALENCE OF ERYTHROVIRUS B19 IgG AMONG SAUDI BLOOD DONORS IN MAKKAH, SAUDI ARABIA.

Authors:  Ayman K Johargy
Journal:  J Family Community Med       Date:  2009-09

Review 4.  Blood coagulation factor VIII: An overview.

Authors:  G M Bhopale; R K Nanda
Journal:  J Biosci       Date:  2003-12       Impact factor: 1.826

5.  Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests.

Authors:  Kati Hokynar; Päivi Norja; Harri Laitinen; Pekka Palomäki; Antoine Garbarg-Chenon; Annamari Ranki; Klaus Hedman; Maria Söderlund-Venermo
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

6.  The genome of human parvovirus b19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus.

Authors:  Wuxiang Guan; Susan Wong; Ning Zhi; Jianming Qiu
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

7.  Parvovirus B19V DNA contamination in Chinese plasma and plasma derivatives.

Authors:  Wei Zhang; Ling Ke; Li Changqing; Yan Zhang; Wuping Li
Journal:  J Transl Med       Date:  2012-09-17       Impact factor: 5.531

8.  Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A.

Authors:  A Dmoszynska; K Kuliczkowski; A Hellmann; J Trelinski; J Kloczko; T Baglin; C Hay; D O'Shaughnessy; K Zawilska; M Makris; R Shaikh-Zaidi; E Gascoigne; C Dash
Journal:  Haemophilia       Date:  2011-03-04       Impact factor: 4.287

9.  Structures and implications of the nuclease domain of human parvovirus B19 NS1 protein.

Authors:  Yixi Zhang; Zhiwei Shao; Yanqing Gao; Boming Fan; Jie Yang; Xi Chen; Xin Zhao; Qiyuan Shao; Weizhen Zhang; Chulei Cao; Hehua Liu; Jianhua Gan
Journal:  Comput Struct Biotechnol J       Date:  2022-08-27       Impact factor: 6.155
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.